Article
Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome
1 Aug 2012
Abstract excerpt
Programmed cell death or apoptosis is a prominent feature of low-risk myelodysplastic syndromes (MDS), although the underlying mechanism remains controversial. High-risk MDS have less apoptosis associated with increased expression of the prosurvival BCL2-related proteins. To address the mechanism and pathogenic role of apoptosis and BCL2 expression in MDS, we used a mouse model resembling human MDS, in which the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
